Nexalin Technology (NXL) FCF Margin Growth (1y) (2022 - 2026)
Nexalin Technology (NXL) FCF Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -473.00 |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | -1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.35 Mn |
| Mar 31, 2026 | -831,042.00 |
| Dec 31, 2025 | 350,623.00 |
| Sep 30, 2025 | -585,810.00 |
| Jun 30, 2025 | 334,455.00 |
| Mar 31, 2025 | -250,707.00 |
| Dec 31, 2024 | 71,503.00 |
| Sep 30, 2024 | 68,664.00 |
| Jun 30, 2024 | -234,896.00 |
| Mar 31, 2024 | 333,163.00 |
| Dec 31, 2023 | -253,003.00 |
| Sep 30, 2023 | -273,448.00 |
| Jun 30, 2023 | -225,574.00 |
| Mar 31, 2023 | -423,899.00 |
| Dec 31, 2022 | -65,447.00 |